148 related articles for article (PubMed ID: 8258620)
1. The effect of local hyperthermia on allergen-induced nasal congestion and mediator release.
Johnston SL; Price JN; Lau LC; Walls AF; Walters C; Feather IH; Holgate ST; Howarth PH
J Allergy Clin Immunol; 1993 Dec; 92(6):850-6. PubMed ID: 8258620
[TBL] [Abstract][Full Text] [Related]
2. Histamine and tryptase in nasal lavage fluid after allergen challenge: effect of 1 week of pretreatment with intranasal azelastine or systemic cetirizine.
Jacobi HH; Skov PS; Poulsen LK; Malling HJ; Mygind N
J Allergy Clin Immunol; 1999 May; 103(5 Pt 1):768-72. PubMed ID: 10329808
[TBL] [Abstract][Full Text] [Related]
3. Effects of fexofenadine on the early response to nasal allergen challenge.
Allocco FT; Votypka V; deTineo M; Naclerio RM; Baroody FM
Ann Allergy Asthma Immunol; 2002 Dec; 89(6):578-84. PubMed ID: 12487223
[TBL] [Abstract][Full Text] [Related]
4. Heparin attenuates symptoms and mast cell degranulation induced by AMP nasal provocation.
Zeng D; Prosperini G; Russo C; Spicuzza L; Cacciola RR; Di Maria GU; Polosa R
J Allergy Clin Immunol; 2004 Aug; 114(2):316-20. PubMed ID: 15316509
[TBL] [Abstract][Full Text] [Related]
5. Basophil and eosinophil accumulation and mast cell degranulation in the nasal mucosa of patients with hay fever after local allergen provocation.
KleinJan A; McEuen AR; Dijkstra MD; Buckley MG; Walls AF; Fokkens WJ
J Allergy Clin Immunol; 2000 Oct; 106(4):677-86. PubMed ID: 11031338
[TBL] [Abstract][Full Text] [Related]
6. Antiallergic actions of high topical doses of terbutaline in human nasal airways.
Svensson C; Greiff L; Andersson M; Alkner U; Grönneberg R; Persson CG
Allergy; 1995 Nov; 50(11):884-90. PubMed ID: 8748720
[TBL] [Abstract][Full Text] [Related]
7. Loratadine reduces allergen-induced mucosal output of alpha 2-macroglobulin and tryptase in allergic rhinitis.
Greiff L; Persson CG; Svensson C; Enander I; Andersson M
J Allergy Clin Immunol; 1995 Jul; 96(1):97-103. PubMed ID: 7542675
[TBL] [Abstract][Full Text] [Related]
8. Effect of six-hour exposure to nitrogen dioxide on early-phase nasal response to allergen challenge in patients with a history of seasonal allergic rhinitis.
Wang JH; Devalia JL; Duddle JM; Hamilton SA; Davies RJ
J Allergy Clin Immunol; 1995 Nov; 96(5 Pt 1):669-76. PubMed ID: 7499684
[TBL] [Abstract][Full Text] [Related]
9. Local and systemic immunotherapy in nasal allergy.
Palma-Carlos AG; Palma-Carlos ML; Spínola Santos A; Santos C; Pedro E; Pregal A
Int J Pediatr Otorhinolaryngol; 1999 Oct; 49 Suppl 1():S207-11. PubMed ID: 10577807
[TBL] [Abstract][Full Text] [Related]
10. IL-13 mRNA and immunoreactivity in allergen-induced rhinitis: comparison with IL-4 expression and modulation by topical glucocorticoid therapy.
Ghaffar O; Laberge S; Jacobson MR; Lowhagen O; Rak S; Durham SR; Hamid Q
Am J Respir Cell Mol Biol; 1997 Jul; 17(1):17-24. PubMed ID: 9224205
[TBL] [Abstract][Full Text] [Related]
11. Effect of salbutamol on nasal symptoms and mast cell degranulation induced by adenosine 5' monophosphate nasal challenge.
Russo C; Zeng D; Prosperini G; Spicuzza L; Guarino F; Polosa R
Clin Exp Allergy; 2005 Sep; 35(9):1192-6. PubMed ID: 16164447
[TBL] [Abstract][Full Text] [Related]
12. Effect of topical levocabastine on nasal response to allergen challenge and nasal hyperreactivity in perennial rhinitis.
de Graaf-in 't Veld T; Garrelds IM; van Toorenenbergen AW; Mulder PG; Gerth van Wijk R; Boegheim JP
Ann Allergy Asthma Immunol; 1995 Sep; 75(3):261-6. PubMed ID: 7552929
[TBL] [Abstract][Full Text] [Related]
13. Low dose clemastine inhibits sneezing and rhinorrhea during the early nasal allergic reaction.
Chung JH; deTineo ML; Naclerio RM; Sorrentino JV; Winslow CM; Baroody FM
Ann Allergy Asthma Immunol; 1997 Mar; 78(3):307-12. PubMed ID: 9087158
[TBL] [Abstract][Full Text] [Related]
14. Nitrogen dioxide increases eosinophil activation in the early-phase response to nasal allergen provocation.
Wang JH; Duddle J; Devalia JL; Davies RJ
Int Arch Allergy Immunol; 1995; 107(1-3):103-5. PubMed ID: 7613114
[TBL] [Abstract][Full Text] [Related]
15. Mast cell tryptase release and asthmatic responses to allergen increase with regular use of salbutamol.
Swystun VA; Gordon JR; Davis EB; Zhang X; Cockcroft DW
J Allergy Clin Immunol; 2000 Jul; 106(1 Pt 1):57-64. PubMed ID: 10887306
[TBL] [Abstract][Full Text] [Related]
16. Measurement of inflammatory mediators of mast cells and eosinophils in native nasal lavage fluid in nasal polyposis.
Di Lorenzo G; Drago A; Esposito Pellitteri M; Candore G; Colombo A; Gervasi F; Pacor ML; Purello D'Ambrosio F; Caruso C
Int Arch Allergy Immunol; 2001 Jun; 125(2):164-75. PubMed ID: 11435734
[TBL] [Abstract][Full Text] [Related]
17. Nasal airway changes assessed by acoustic rhinometry and mediator release during immediate and late reactions to allergen challenge.
Zweiman B; Getsy J; Kalenian M; Lane A; Schwartz LB; Doty R; Lanza D
J Allergy Clin Immunol; 1997 Nov; 100(5):624-31. PubMed ID: 9389292
[TBL] [Abstract][Full Text] [Related]
18. Attenuation of allergen-evoked nasal responses by local pretreatment with exogenous neuropeptide Y in atopic patients.
Lacroix JS; Mosimann BL
J Allergy Clin Immunol; 1996 Sep; 98(3):611-6. PubMed ID: 8828539
[TBL] [Abstract][Full Text] [Related]
19. Tryptase in nasal fluid is a useful marker of allergic rhinitis.
Rasp G; Hochstrasser K
Allergy; 1993 Feb; 48(2):72-4. PubMed ID: 8457035
[TBL] [Abstract][Full Text] [Related]
20. Concentrations of chemical mediators in nasal secretions after nasal allergen challenges in atopic patients.
Wang D; Clement P; Smitz J; Derde MP
Eur Arch Otorhinolaryngol; 1995; 252 Suppl 1():S40-3. PubMed ID: 7734974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
